Ayla Balkan

519 total citations
32 papers, 419 citations indexed

About

Ayla Balkan is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Ayla Balkan has authored 32 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 7 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Ayla Balkan's work include Synthesis and biological activity (18 papers), Synthesis and Characterization of Heterocyclic Compounds (11 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Ayla Balkan is often cited by papers focused on Synthesis and biological activity (18 papers), Synthesis and Characterization of Heterocyclic Compounds (11 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Ayla Balkan collaborates with scholars based in Türkiye, India and Serbia. Ayla Balkan's co-authors include Oya Ünsal Tan, Keriman Ozadali‐Sari, Ayşe Kevser Pişkin, Tuba Tüylü Küçükkılınç, Dharmarajan Sriram, Perumal Yogeeswari, Beyza Ayazgök, Arvi Rauk, Mevlüt Ertan and Selma Saraç and has published in prestigious journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and Journal of the Chemical Society Perkin Transactions 1.

In The Last Decade

Ayla Balkan

30 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayla Balkan Türkiye 12 327 121 95 81 26 32 419
Keriman Ozadali‐Sari Türkiye 12 401 1.2× 143 1.2× 114 1.2× 102 1.3× 26 1.0× 22 497
Barkın Berk Türkiye 13 251 0.8× 92 0.8× 219 2.3× 123 1.5× 25 1.0× 49 493
Atukuri Dorababu India 14 428 1.3× 54 0.4× 128 1.3× 54 0.7× 22 0.8× 36 545
O. Ozgen Türkiye 5 421 1.3× 77 0.6× 82 0.9× 55 0.7× 13 0.5× 7 506
Nitin Kumar India 13 497 1.5× 60 0.5× 143 1.5× 52 0.6× 14 0.5× 35 645
Tedman Ehlers United States 5 152 0.5× 75 0.6× 190 2.0× 77 1.0× 9 0.3× 8 384
Noor ul Amin Mohsin Pakistan 10 229 0.7× 96 0.8× 101 1.1× 42 0.5× 8 0.3× 29 377
Kazuhiko Iwase United Kingdom 11 246 0.8× 90 0.7× 176 1.9× 46 0.6× 18 0.7× 12 427
Jean‐Marie Contreras France 6 199 0.6× 111 0.9× 111 1.2× 120 1.5× 5 0.2× 7 325
Ahmet Çağrı Karaburun Türkiye 14 615 1.9× 150 1.2× 179 1.9× 97 1.2× 29 1.1× 28 718

Countries citing papers authored by Ayla Balkan

Since Specialization
Citations

This map shows the geographic impact of Ayla Balkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayla Balkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayla Balkan more than expected).

Fields of papers citing papers by Ayla Balkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayla Balkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayla Balkan. The network helps show where Ayla Balkan may publish in the future.

Co-authorship network of co-authors of Ayla Balkan

This figure shows the co-authorship network connecting the top 25 collaborators of Ayla Balkan. A scholar is included among the top collaborators of Ayla Balkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayla Balkan. Ayla Balkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tan, Oya Ünsal, et al.. (2022). Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors. Bioorganic Chemistry. 121. 105696–105696. 26 indexed citations
3.
Tan, Oya Ünsal, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, Ayla Balkan, & Keriman Ozadali‐Sari. (2019). Synthesis, molecular docking, and biological evaluation of novel 2-pyrazoline derivatives as multifunctional agents for the treatment of Alzheimer's disease. MedChemComm. 10(6). 1018–1026. 15 indexed citations
4.
Ozadali‐Sari, Keriman, Oya Ünsal Tan, Dharmarajan Sriram, & Ayla Balkan. (2019). Some New Hydrazone Derivatives Bearing the 1,2,4-Triazole Moiety as Potential Antimycobacterial Agents. Turkish Journal of Pharmaceutical Sciences. 16(4). 432–436. 7 indexed citations
5.
Ozadali‐Sari, Keriman, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, Ayla Balkan, & Oya Ünsal Tan. (2017). Novel multi-targeted agents for Alzheimer's disease: Synthesis, biological evaluation, and molecular modeling of novel 2-[4-(4-substitutedpiperazin-1-yl)phenyl]benzimidazoles. Bioorganic Chemistry. 72. 208–214. 37 indexed citations
6.
Ozadali‐Sari, Keriman, Oya Ünsal Tan, Perumal Yogeeswari, Dharmarajan Sriram, & Ayla Balkan. (2014). Synthesis and antimycobacterial activities of some new thiazolylhydrazone derivatives. Bioorganic & Medicinal Chemistry Letters. 24(7). 1695–1697. 28 indexed citations
7.
8.
Tan, Oya Ünsal, Keriman Ozadali‐Sari, Ayşe Kevser Pişkin, & Ayla Balkan. (2012). Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity. European Journal of Medicinal Chemistry. 57. 59–64. 64 indexed citations
9.
Tan, Oya Ünsal, Ayşe Kevser Pişkin, Arvi Rauk, & Ayla Balkan. (2010). Synthesis and cyclooxygenase inhibitory activities of some N-acylhydrazone derivatives of isoxazolo[4,5-d]pyridazin-4(5H)-ones. European Journal of Medicinal Chemistry. 45(6). 2345–2352. 51 indexed citations
10.
Balkan, Ayla & Barkın Berk. (2003). Novel Approaches to Anti-Inflammatory Agents as Therapeutics for Asthma. 2(1). 9–18. 4 indexed citations
11.
Bebi̇toğlu, Berna Terzi̇oğlu, et al.. (2003). Studies on Some 3-Oxo-5-benzylidene-6- methyl-(4H) - 2 - substitutedpyridazines with Antinociceptive and Antiinflammatory Activities. Dspace Repository (Marmara Üniversitesi). 3 indexed citations
12.
Balkan, Ayla, et al.. (1997). New naphthyloxyalkyl beta-diketone and 3,5-dimethylisoxazole derivatives as potential antiviral agents.. PubMed. 51(8-9). 589–94. 1 indexed citations
13.
Spencer, Nicholas D., et al.. (1997). The phototransformation of 5-tert-butyl-2′-deoxyuridine: an approach to the synthesis of new 1,2-dihydrocyclobuta[d ]pyrimidin-2-ones1. Journal of the Chemical Society Perkin Transactions 1. 121–126. 2 indexed citations
14.
Balkan, Ayla, et al.. (1996). New thiazolo[3,2-a] pyrimidine derivatives, synthesis and calcium antagonistic activities.. PubMed. 135(11). 648–52. 3 indexed citations
15.
Balkan, Ayla, et al.. (1994). The Synthesis of Some 5-Substituted and 5,6-Disubstituted 2′-Deoxyuridines. Nucleosides and Nucleotides. 13(1-3). 177–196. 11 indexed citations
16.
17.
Balkan, Ayla, Mevlüt Ertan, & Thomas Burgemeister. (1992). Synthesis and Structural Evaluations of Thiazolo[3,2‐a]pyrimidine Derivatives. Archiv der Pharmazie. 325(8). 499–501. 13 indexed citations
18.
Ertan, Mevlüt, et al.. (1991). Synthesis and Calcium Antagonistic Activity of Some New 2‐Thioxo‐1,2,3,4‐tetrahydropyrimidine Derivatives. Archiv der Pharmazie. 324(3). 135–139. 18 indexed citations
19.
Saraç, Selma, Mevlüt Ertan, Ayla Balkan, & Nuran Yuluğ. (1991). Synthesis and Antimicrobial Activities of Some New Tetrahydro‐2H‐1,3,5‐thiadiazine‐2‐thione Derivatives of Cefadroxil. Archiv der Pharmazie. 324(7). 449–453. 11 indexed citations
20.
Balkan, Ayla, et al.. (1991). Synthesis and biological evaluations of some 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives.. PubMed. 41(7). 725–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keriman Ozadali‐Sari Breakdown of academic impact, for papers by Barkın Berk Breakdown of academic impact, for papers by Atukuri Dorababu Breakdown of academic impact, for papers by O. Ozgen Breakdown of academic impact, for papers by Nitin Kumar Breakdown of academic impact, for papers by Tedman Ehlers Breakdown of academic impact, for papers by Noor ul Amin Mohsin Breakdown of academic impact, for papers by Kazuhiko Iwase Breakdown of academic impact, for papers by Jean‐Marie Contreras Breakdown of academic impact, for papers by Ahmet Çağrı Karaburun
Rankless by CCL
2026